Loading…
Bacil Pharma (BSE 524516)₹16.82−1.29%Pharmaceuticals
At the end of the Sep 2026 quarter, Bacil Pharma's shareholders were: promoters 0.00%, public 100.00%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 7,692 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 42.62% | 42.62% | 42.62% | 20.66% | 10.55% | 0.20% | 0.20% | 0.08% | 0.08% | 0.00% | 0.00% | 0.00% |
| Public | 57.38% | 57.38% | 57.38% | 79.34% | 89.45% | 99.80% | 99.80% | 99.92% | 99.92% | 100.00% | 100.00% | 100.00% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,629 | 6,771 | 6,795 | 6,903 | 7,462 | 7,639 | 7,533 | 7,432 | 7,432 | 7,227 | 7,327 | 7,692 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Vicky Pratapbhai Shah | Public | 16.55% | 0.00 |
| Nikita Hiren Patel | Public | 9.61% | −0.49 |
| Manubhai Amrutlal Shah | Public | 7.86% | −2.02 |
| Chhaya Gaurang Shah | Public | 6.42% | −0.27 |
| Jr Seamless Private Limited | Public | 5.54% | New |
| Manmohan Jagdishprasad Ghuwalewala | Public | 4.21% | 0.00 |
| Navin Keshrimal Mehta | Public | 2.19% | 0.00 |
| Shrynax Trading Private Limited | Public | 2.08% | New |
| Purshottam R Bohra | Public | 2.04% | New |
| Brenley Engineers Private Limited | Public | 1.80% | New |
| Deepa Navin Mehta | Public | 1.73% | 0.00 |
| Amnesti Multiservices Private Limited | Public | 1.44% | New |
| Saroj Kishor Mehta | Public | 1.15% | 0.00 |
| Niraj Rajnikant Shah | Public | Exited | — |
| Vishal Mahesh Waghela | Public | Exited | — |
| Hemang Rajendra Doshi | Public | Exited | — |
| Dinesh Ishvarbhai Lalwani | Public | Exited | — |
| Gulecha Investment & Trading Co Pvt Ltd | Promoter | 0.00% | 0.00 |
| Lal Lachhmandas Hingorani | Promoter | 0.00% | 0.00 |
Promoters held 0.00% of Bacil Pharma at the end of the Sep 2026 quarter, down 0.08 percentage points from 0.08% a year earlier.
No. The Sep 2026 filing shows no pledged promoter shares.
Bacil Pharma had 7,692 shareholders at the end of the Sep 2026 quarter, against 7,432 a year earlier.
Vicky Pratapbhai Shah (Public) held 16.55% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.